YOLFTbeta
Pacific Shuanglin Bio pharmacy Co Ltd

Pacific Shuanglin Bio pharmacy Co Ltd

000403 · SHE · Healthcare / Biotechnology

8.99CNY-0.21 (-2.28%)

Price History

Full chart

Market Stats

Previous Close9.20
Open9.23
Day Range8.97 – 9.24
52-Week Range8.54 – 16.58
Volume7.49M
Market Cap9.56B
P/E (TTM)35.93
Forward P/E0.00
EPS0.28
Dividend Yield0.00%
Beta0.45
50-Day Avg10.33
200-Day Avg12.02

About

Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of blood products in China and internationally. The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen, lyophilized intravenous immunoglobulin (pH4), hepatitis B immunoglobulin (pH4), and human prothrombin complex concentrate, as well as intravenous cytomegalovirus immunoglobulin and intravenous respiratory syncytial virus immunoglobulin. It is also involved in blood acquisition; plasma collection; consulting; trading; investment activities; and technology promotion and application services. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is headquartered in Taiyuan, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Xiankui Rong
  • Employees2.75K
  • HeadquartersSunshine City Global Financial Center, Taiyuan, China, 030000, China
  • Websitehttps://www.slbiop.com

Leadership

  • Mr. Xiankui RongGeneral Manager · b. 1974
  • Ms. Yehong WangCFO, Head of Accounting Department & Accounting Supervisor · b. 1991
  • Mr. Lei YanDeputy GM & Director · b. 1991
  • Mr. Wenbin SiDeputy GM & Non-Independent Director · b. 1981
  • Ms. Xiaoying HuangDeputy GM & Non-Independent Director · b. 1974
  • Ms. Lan YeDeputy GM & Non-Independent Director · b. 1979
  • Mr. Yulin ZhaoBoard Secretary · b. 1987
  • Mr. Qunge ZhangDeputy General Manager · b. 1970

Financials

Income Statement

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue141.89M143.33M157.45M191.57M349.95M381.18M422.25M467.96M651.81M741.37M742.95M674.90M645.03M578.80M465.91M545.67M456.92M469.82M477.72M489.50M500.27M561.21M685.38M859.84M915.66M1.05B1.97B2.41B2.33B2.65B2.63B
Growth (%)-+1.02%+9.85%+21.67%+82.67%+8.92%+10.77%+10.82%+39.29%+13.74%+0.21%-9.16%-4.43%-10.27%-19.50%+17.12%-16.27%+2.82%+1.68%+2.47%+2.20%+12.18%+22.12%+25.46%+6.49%+14.67%+87.80%+21.98%-3.18%+14.00%-0.83%
Cost of Revenue105.92M105.12M111.78M125.76M211.79M211.35M256.88M326.37M501.31M535.22M605.23M558.55M481.67M416.16M248.67M242.25M152.06M185.91M192.58M231.00M235.54M247.03M295.65M401.33M438.83M537.36M1.06B1.15B1.13B1.35B1.54B
Gross Profit35.97M38.21M45.67M65.81M138.16M169.83M165.37M141.58M150.50M146.03M137.72M116.35M163.36M162.64M217.24M303.43M309.01M283.91M285.13M258.50M264.73M314.19M389.73M458.52M476.83M512.58M907.93M1.25B1.20B1.30B1.09B
Gross Margin25.35%26.66%29.01%34.35%39.48%44.55%39.16%30.26%23.09%19.70%18.54%17.24%25.33%28.10%46.63%55.61%67.63%60.43%59.69%52.81%52.92%55.98%56.86%53.33%52.08%48.82%46.05%52.13%51.48%49.08%41.53%
Operating Expense23.13M18.28M24.34M33.98M50.55M47.12M81.66M98.29M115.47M305.78M583.10M120.06M194.90M162.68M237.62M231.94M161.91M133.30M226.27M158.25M196.41M254.61M306.09M365.05M296.79M292.28M447.50M590.44M503.66M422.72M506.90M
Operating Income12.84M19.93M21.33M31.83M87.61M122.72M83.71M43.29M35.03M-159.75M-445.38M-3.70M-31.54M-37.19K-20.38M71.48M147.09M150.62M58.87M100.25M68.32M59.58M83.64M93.46M180.04M220.30M460.43M663.43M695.19M880.31M586.54M
Operating Margin9.05%13.90%13.55%16.62%25.04%32.19%19.82%9.25%5.37%-21.55%-59.95%-0.55%-4.89%-0.01%-4.37%13.10%32.19%32.06%12.32%20.48%13.66%10.62%12.20%10.87%19.66%20.98%23.35%27.58%29.85%33.16%22.28%
EBITDA18.61M20.69M24.42M47.81M96.43M140.38M144.87M103.16M103.82M-68.64M-603.01M81.93M235.56M301.40M74.41M68.90M88.63M181.05M159.67M165.25M147.10M127.79M158.46M166.52M237.17M273.96M538.01M704.63M770.71M913.93M660.62M
EBITDA Margin13.12%14.43%15.51%24.96%27.55%36.83%34.31%22.04%15.93%-9.26%-81.16%12.14%36.52%52.07%15.97%12.63%19.40%38.54%33.42%33.76%29.40%22.77%23.12%19.37%25.90%26.09%27.29%29.30%33.10%34.43%25.09%
Net Income8.36M16.60M20.68M21.38M80.17M109.14M78.91M44.92M24.00M-198.21M-663.66M-87.19M34.61M202.01M2.33M29.23M40.71M32.57M70.28M122.52M77.56M50.09M21.60M79.98M160.45M185.97M391.06M587.13M612.11M745.32M419.27M
Net Income Margin5.89%11.58%13.13%11.16%22.91%28.63%18.69%9.60%3.68%-26.74%-89.33%-12.92%5.37%34.90%0.50%5.36%8.91%6.93%14.71%25.03%15.50%8.93%3.15%9.30%17.52%17.71%19.83%24.41%26.29%28.08%15.93%
R&D---------------28.38M28.46M16.31M26.88M19.09M24.13M26.77M29.39M28.59M14.73M11.00M35.63M75.36M79.69M58.60M55.92M
R&D as % of Total Revenue---------------5.20%6.23%3.47%5.63%3.90%4.82%4.77%4.29%3.32%1.61%1.05%1.81%3.13%3.42%2.21%2.12%
Interest Expense4.72M9.08M6.94M9.12M14.17M12.80M21.38M29.33M36.53M51.63M85.35M98.74M86.98M46.97M41.89M20.55M21.94M34.42M70.61M37.05M31.26M30.88M28.28M26.04M21.92M19.37M12.61M12.27M9.98M11.22M18.19M
Interest Expense % of Total Revenue3.32%6.33%4.41%4.76%4.05%3.36%5.06%6.27%5.61%6.96%11.49%14.63%13.48%8.12%8.99%3.77%4.80%7.33%14.78%7.57%6.25%5.50%4.13%3.03%2.39%1.85%0.64%0.51%0.43%0.42%0.69%

Balance Sheet

Currency: CNY1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets190.95M191.55M199.43M330.76M397.33M523.91M960.75M1.18B1.38B1.54B2.24B2.12B2.08B1.71B1.66B1.21B1.25B925.41M960.80M1.07B1.19B1.19B1.27B1.24B1.32B1.32B1.27B1.65B7.09B7.98B8.63B9.25B9.47B
Total Liabilities134.65M134.01M135.07M175.67M192.19M288.28M478.92M579.29M690.82M765.52M1.40B1.51B1.97B1.73B1.65B1.04B1.11B651.42M678.06M780.27M835.47M735.16M739.82M696.41M761.70M698.08M470.04M685.71M760.07M1.12B1.21B1.33B1.39B
Total Equity56.30M57.54M64.35M155.09M205.14M228.30M452.06M551.47M620.45M706.73M730.63M540.04M-10.63M-192.29M-185.66M1.26M3.57M156.78M197.49M230.06M300.34M422.89M500.46M554.35M571.95M637.73M800.22M965.32M6.33B6.87B7.43B7.92B8.09B
Cash4.54M318.70K3.62M1.96M8.46M8.56M110.60M173.44M260.30M357.90M268.58M38.02M27.99M18.74M23.15M8.27M61.75M15.01M52.55M37.92M16.03M43.70M51.64M202.82M145.87M154.77M110.94M102.83M885.67M1.00B1.43B1.32B770.16M
Total Debt66.57M89.12M80.43M67.76M88.55M144.00M255.52M280.36M406.82M463.75M1.03B1.04B1.34B1.05B949.57M480.54M496.91M279.17M240.18M279.96M333.46M281.95M286.95M247.00M224.00M180.00M110.00M352.43M141.46M373.36M468.13M632.32M-
Net Debt62.02M88.80M76.81M65.80M80.09M135.44M144.92M106.92M146.52M105.85M765.97M1.00B1.31B1.04B926.42M472.27M435.16M264.17M187.63M242.04M317.43M238.25M235.31M44.18M78.13M25.23M-943.11K249.60M-744.21M-627.44M-933.33M-688.81M-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.65M-23.08M27.36M111.28M159.18M-49.47M-131.73M49.06M-10.42M95.03M74.90M111.86M9.88M130.14M123.24M91.01M77.04M70.31M62.49M-35.91M116.63M190.84M194.84M408.22M524.22M679.01M321.79M-215.99M
Investing Cash Flow-27.13M-86.41M-11.31M-111.28M-88.09M-331.44M-85.79M-5.75M-6.95M-5.23M-32.26M-61.84M-34.35M-73.36M-180.25M-150.19M6.64M-59.39M150.80M-36.22M-10.49M-29.80M-302.81M-678.28M-556.38M-366.84M-335.94M-
Financing Cash Flow29.88M211.53M46.79M86.86M26.52M289.74M-13.04M-55.11M8.12M-85.39M-57.53M-2.67M-16.14M-19.23M42.38M37.29M-56.05M-2.98M-62.10M-14.79M-67.35M-204.77M96.66M1.06B148.46M38.24M-93.74M-
Capital Expenditure11.23M86.42M56.62M87.96M89.09M154.17M94.64M6.95M7.54M6.31M43.59M70.29M36.46M73.58M180.28M162.99M71.05M59.39M98.03M39.87M35.02M41.11M40.18M326.16M378.64M377.27M520.71M333.40M
Free Cash Flow-13.88M-109.50M-29.25M23.32M70.09M-203.64M-226.37M42.11M-17.96M88.72M31.31M41.57M-26.58M56.56M-57.04M-71.98M5.99M10.92M-35.54M-75.78M81.61M149.73M154.66M82.06M145.58M301.74M-198.92M-549.39M
Dividends Paid14.57M15.64M16.76M40.87M29.34M37.23M47.62M49.45M19.56M39.06M23.31M19.45M4.23M5.32M10.02M16.21M10.08M7.98M30.88M5.01M23.27M144.61M32.84M140.54K41.05M58.61M264.63M273.80M
FCF to OCF524.35%474.52%-106.91%20.95%44.03%411.65%171.84%85.83%172.40%93.36%41.80%37.16%-269.10%43.46%-46.28%-79.10%7.78%15.53%-56.88%211.03%69.97%78.46%79.38%20.10%27.77%44.44%-61.82%254.36%
Dividend Paid to FCF-104.99%-14.28%-57.27%175.27%41.86%-18.28%-21.04%117.43%-108.91%44.03%74.43%46.78%-15.91%9.40%-17.57%-22.52%168.28%73.10%-86.88%-6.61%28.51%96.58%21.23%0.17%28.20%19.42%-133.03%-49.84%

Earnings

Report DateMar 31, 2003Jun 30, 2003Sep 30, 2003Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jul 19, 2014Oct 19, 2014Feb 20, 2015Apr 19, 2015Jul 19, 2015Oct 19, 2015Dec 31, 2015Apr 28, 2016Aug 31, 2016Oct 27, 2016Dec 31, 2016Apr 28, 2017Aug 30, 2017Oct 27, 2017Apr 30, 2018Aug 31, 2018Oct 30, 2018Dec 31, 2018Apr 29, 2019Aug 23, 2019Oct 18, 2019Mar 17, 2020Apr 29, 2020Aug 27, 2020Oct 25, 2020Mar 23, 2021Apr 28, 2021Aug 27, 2021Oct 19, 2021Dec 31, 2021Apr 15, 2022Aug 29, 2022Oct 30, 2022Dec 31, 2022Apr 28, 2023Aug 23, 2023Oct 30, 2023Apr 26, 2024Aug 27, 2024Oct 27, 2024Dec 31, 2024Apr 23, 2025Aug 21, 2025Oct 29, 2025Apr 30, 2026Aug 24, 2026
EPS Estimate--------------------------------------------------------------0.250.220.250.220.250.24--
EPS Actual0.010.020.01-0.000.000.02-0.020.010.010.01-0.000.020.010.010.010.020.020.02-0.020.040.040.05-0.020.16-0.010.040.010.030.080.030.020.040.050.03-0.010.040.050.050.060.080.03-0.000.050.110.100.070.050.140.080.170.090.160.180.090.140.160.180.250.320.120.250.170.280.230.220.090.160.130.020.07
Surprise--------------------------------------------------------------12.00%4.55%-12.51%-59.09%-36.00%-45.83%--
Timing------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market-Pre-marketPre-marketAfter-hoursPre-market-Pre-market-Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hoursAfter-hours---

Key Statistics & Ratios

Market Cap9.56B
Enterprise Value9.75B
Trailing P/E35.93
Forward P/E0.00
Price / Sales3.86
Price / Book1.19
EPS0.28
Book Value8.59
Revenue (TTM)2.48B
Gross Profit (TTM)893.27M
EBITDA533.08M
Profit Margin10.82%
Operating Margin12.95%
Return on Equity3.37%
Return on Assets2.59%
Shares Outstanding950.40M
Shares Float525.83M
Beta0.45
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.15Oct 23, 2026
20251×
0.27Jun 4, 2025
20242×
0.12Dec 17, 20240.15Jun 28, 2024
20231×
0.06Jul 20, 2023
20221×
0.04Jul 15, 2022
20201×
0.09Jul 27, 2020

Stock Splits

  • Jun 4, 20251.3:1
  • Jul 27, 20201.9527:1